According to the Cancer Genome Atlas (TCGA) genetic screening, 86% of human glioblastoma samples harbor at least one genetic alteration event in the core RTK pathways, and EGFR, PDGFRα, and MET are most commonly amplified RTKs in glioblastomas (20, 21). The gene discussed is MET; the disease is glioblastoma.